Certified by Founder Lodge
Mubadala Capital
United Arab Emirates - Abu Dhabi
INVESTOR
1 Disclosed Funding Rounds $70,000,000
44 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mubadala Capital is the wholly owned asset management arm of Mubadala Investment Company. Since its inception a decade ago, Mubadala Capital has grown to become a global asset manager of sign
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 09 ,2022 | Series B | $70,000,000.00 |
| Company | Date | Round | Raised |
|---|---|---|---|
 Flip(US) |
April, 09 ,2024 | Series C | $144,000,000 |
 Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
 Tabby |
January, 18 ,2023 | Unknown | $58,000,000 |
 Ramp Network |
November, 09 ,2022 | Series B | $70,000,000 |
 Arbol(US) |
May, 01 ,2024 | Series B | $60,000,000 |
 Neumora |
October, 17 ,2022 | Series B | $112,000,000 |
| Flip(US) |
April, 09 ,2024 | Series C | $144,000,000 |
 Spotnana |
July, 26 ,2022 | Series B | $75,000,000 |
 Storyblok |
June, 04 ,2024 | Series C | $80,000,000 |
| Tabby |
January, 18 ,2023 | Unknown | $58,000,000 |
| Arbol(US) |
May, 01 ,2024 | Series B | $60,000,000 |
 Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Spotnana |
July, 26 ,2022 | Series B | $75,000,000 |
 Outpace Bio |
August, 02 ,2024 | Series B | $144,000,000 |
| Storyblok |
June, 04 ,2024 | Series C | $80,000,000 |
 xilis |
July, 13 ,2022 | Series A | $89,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
 Juni |
June, 09 ,2022 | Series B | $206,000,000 |
| Outpace Bio |
August, 02 ,2024 | Series B | $144,000,000 |
 Unlearn.AI |
April, 19 ,2022 | Series B | $50,000,000 |
| xilis |
July, 13 ,2022 | Series A | $89,000,000 |
 Welcome Tech |
April, 14 ,2022 | Unknown | $30,000,000 |
| Juni |
June, 09 ,2022 | Series B | $206,000,000 |
| Tabby |
March, 07 ,2022 | Series B | $54,000,000 |
| Unlearn.AI |
April, 19 ,2022 | Series B | $50,000,000 |
 Georgiamune Inc. |
August, 10 ,2023 | Series A | $75,000,000 |
| Welcome Tech |
April, 14 ,2022 | Unknown | $30,000,000 |
| Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
| Tabby |
March, 07 ,2022 | Series B | $54,000,000 |
| Flip(US) |
April, 09 ,2024 | Series C | $144,000,000 |
| Georgiamune Inc. |
August, 10 ,2023 | Series A | $75,000,000 |
| Arbol(US) |
May, 01 ,2024 | Series B | $60,000,000 |
| Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
| Storyblok |
June, 04 ,2024 | Series C | $80,000,000 |
| Flip(US) |
April, 09 ,2024 | Series C | $144,000,000 |
| Outpace Bio |
August, 02 ,2024 | Series B | $144,000,000 |
| Arbol(US) |
May, 01 ,2024 | Series B | $60,000,000 |
 GC Therapeutics |
September, 24 ,2024 | Series A | $65,000,000 |
| Storyblok |
June, 04 ,2024 | Series C | $80,000,000 |
 Tenvie Therapeutics |
January, 09 ,2025 | Unknown | $200,000,000 |
| Outpace Bio |
August, 02 ,2024 | Series B | $144,000,000 |
| GC Therapeutics |
September, 24 ,2024 | Series A | $65,000,000 |
| Tenvie Therapeutics |
January, 09 ,2025 | Unknown | $200,000,000 |
 Light Horse Therapeutics |
January, 10 ,2025 | Series A | $62,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
